These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 813933)

  • 41. IgA antibody response in acute rubella determined by solid-phase radioimmunoassay.
    Halonen P; Meurman O; Matikainen MT; Torfason E; Bennich H
    J Hyg (Lond); 1979 Aug; 83(1):69-75. PubMed ID: 458143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subclass distribution of IgG and IgA responses to rubella virus in man.
    Stokes A; Mims CA; Grahame R
    J Med Microbiol; 1986 Jun; 21(4):283-5. PubMed ID: 3723581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of radial haemolysis with haemagglutination inhibition in estimating rubella antibody.
    Appleton PN; Macrae AD
    J Clin Pathol; 1978 May; 31(5):479-82. PubMed ID: 649774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simplified method for the detection of rubella-specific IgM employing sucrose density fractionation and 2-mercaptoethanol.
    Caul EO; Smyth GW; Clarke SK
    J Hyg (Lond); 1974 Dec; 73(3):329-40. PubMed ID: 4216603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of isotype-specific humoral immunity in rubella vaccine-associated arthropathy.
    Tingle AJ; Pot KH; Yong FP; Puterman ML; Hancock EJ
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S99-106. PubMed ID: 2791348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination.
    Asahi T; Ueda K; Hidaka Y; Miyazaki C; Tanaka Y; Nishima S
    Vaccine; 1997 Nov; 15(16):1791-5. PubMed ID: 9364685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trial of high-titre human rubella immunoglobulin.
    Urquhart GE; Crawford RJ; Wallace J
    Br Med J; 1978 Nov; 2(6148):1331-2. PubMed ID: 363233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The derivation of a minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A Public Health Laboratory Service collaborative survey.
    Bradstreet CM; Kirkwood B; Pattison JR; Tobin JO
    J Hyg (Lond); 1978 Dec; 81(3):383-8. PubMed ID: 366017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adults.
    Paradise JE; Nemorofsky D; Huggins GR; Sondheimer SJ; Plotkin SA
    J Adolesc Health Care; 1984 Apr; 5(2):75-8. PubMed ID: 6368506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rubella immunization of volunteers via the respiratory tract.
    Ganguly R; Ogra PL; Regas S; Waldman RH
    Infect Immun; 1973 Oct; 8(4):497-502. PubMed ID: 4200537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.
    Hillary IB; Griffith AH
    Br Med J; 1980 Jun; 280(6231):1580-1. PubMed ID: 7427177
    [No Abstract]   [Full Text] [Related]  

  • 55. Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization.
    Scott RM; Dudding BA; Romano SV; Russell PK
    Infect Immun; 1972 Mar; 5(3):300-4. PubMed ID: 4629075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus.
    Cusi MG; Valensin PE; Cellesi C
    Arch Virol; 1993; 129(1-4):337-40. PubMed ID: 8470956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experiments with simultaneous immunization against cytomegalovirus infection and rubella].
    Just M; Bürgin-Wolff A; Hernandez R
    Soz Praventivmed; 1976; 21(5):201-4. PubMed ID: 186979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of single-radial-haemolysis for rubella antibody studies.
    Clarke M; Boustred J; Seagroatt V; Schild GC
    J Hyg (Lond); 1977 Dec; 79(3):355-64. PubMed ID: 411831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elution patterns of rubella IgM, IgA, and IgG antibodies from a dextran and an agarose gel.
    Pattison JR; Mace JE
    J Clin Pathol; 1975 Aug; 28(8):670-3. PubMed ID: 1184766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-up studies of rubella vaccinees at adolescence.
    Rauh JL; Schiff GM; Johnson LB
    J Pediatr; 1975 Jan; 86(1):138-40. PubMed ID: 1110437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.